TCRX CIK: 1783328

TScan Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−48.7
FY22:
−66.5
FY23:
−61.4
FY24:
−111
FY25:
−135
Change from FY21 to FY25
millions USD
FY21:
−9.94
FY22:
−4.23
FY23:
−60.8
FY24:
−52.6
FY25:
109
Change from FY21 to FY25
millions USD
FY21:
190
FY22:
29.4
FY23:
135
FY24:
209
FY25:
−0.34
millions USD
FY21:
131
FY22:
−41.4
FY23:
13.3
FY24:
45.3
FY25:
−26.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−58.6
FY22:
−70.7
FY23:
−64.5
FY24:
−115
FY25:
−140

All amounts in millions USD Data source:SEC EDGAR